Nature biotechnology
FDA approves new mechanism to treat idiopathic pulmonary fibrosis, expanding limited arsenal.
Cormac Sheridan
Published: 202510.1038/s41587-025-02908-1
No abstract available for this study.
Cormac Sheridan
No abstract available for this study.